Prof Thomas Coffman is the Dean of Duke-NUS Medical School in Singapore and the James R. Clapp Professor of Medicine at Duke University School of Medicine. Before moving to Singapore, Dr. Coffman held several leadership positions at Duke, including Chief of the Division of Nephrology, Vice-Chair of the Department of Medicine, and Founding Director of the Duke Cardiovascular Research Center. He was also the Founding Director of the Duke-NUS Cardiovascular and Metabolic Disorders Signature Research Program. Dr. Coffman serves on the Boards of Directors for Singapore Health Services (SingHealth) the largest public hospital cluster in Singapore, the Singapore Eye Research Institute, the Singapore National Medical Research Council, and the King Faisal Specialty Hospital and Research Center in Saudi Arabia.
An international leader in the field of nephrology, Dr. Coffman was a Councilor and Past-President of the American Society of Nephrology and served as Treasurer for the International Society of Nephrology. He is a member of the American Society for Clinical Investigation and the Association of American Physicians and served as a member of the Nephrology Subspecialty Board of the American Board of Internal Medicine. He has held a number of editorial positions including Associate Editor for the Journal of Clinical Investigation, and currently serves on the editorial advisory board of Cell Metabolism. Dr. Coffman has been a productive researcher publishing over 200 scientific papers with h-index of 79, and he has been funded for many years by the US National Institutes of Health. His laboratory has made seminal contributions to understanding hypertension, the renin-angiotensin system, and diabetic nephropathy. In 2014, he received the Excellence Award for Hypertension Research from the American Heart Association. Dr. Coffman currently serves as the lead investigator for DYNAMO (Diabetes studY of Nephropathy And other Microvascular cOmplications), a S$250M Large Collaborative Grant funded by the National Medical Research Council of Singapore.
Day 2, 13 October 2023 , Friday, 1645 - 1730hrs
Session 8: 13 Oct 2023, Fri, 1600 - 1730hrs
Track : Track 4C: Precision Medicine - Precision Diabetes & Metabolic Health (GARNET 218 – 219)
Topic : Panel Discussion: All Models Are Wrong. Some Are Useful – Discussion On Sub-Phenotyping Type 2 Diabetes For Precision Care